야간뇨와 호흡곤란으로 발현된 신장을 침범한 특발성 호산구 증가 증후군 1예
A Case of Idiopathic Hypereosinophilic Syndrome Presenting with Nocturia and Dyspnea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Idiopathic hypereosinophilic syndrome (HES) is characterized by marked (>1,500/μL) and persistent (>6months) eosinophilia without an identifiable underlying cause. This condition is associated with multiorgan involvements. Renal involvement is rarely reported and little is known about renal morphologic changes in this disease. We report a case of HES with renal involvement presenting with nocturia and dyspnea. A 30-year-old man visited to our institution due to nocturia and dyspnea. Peripheral blood tests showed an increased eosinophil count (14,868/mm3). Chest CT showed extensive areas of ground-glass opacities in both lungs. Renal biopsy showed thrombotic microangiopathic nephropathy. Based upon his medical records, physical examination findings and laboratory data, he was diagnosed as having idiopatic HES with renal involvement. We found FIP1-like-1-platelet-derived growth factor receptor-α(FIP1L1-PDGFRα) gene rearrangement on BM aspiration. He was treated with oral glucocorticoid and tyrosine kinase inhibitor (imatinib mesylate). His symptoms were improved and proteinuria disappeared.
Abstract
Idiopathic hypereosinophilic syndrome (HES) is characterized by marked (>1,500/μL) and persistent (>6months) eosinophilia without an identifiable underlying cause. This condition is associated with multiorgan involvements. Renal involvement is rarely reported and little is known about renal morphologic changes in this disease. We report a case of HES with renal involvement presenting with nocturia and dyspnea. A 30-year-old man visited to our institution due to nocturia and dyspnea. Peripheral blood tests showed an increased eosinophil count (14,868/mm3). Chest CT showed extensive areas of ground-glass opacities in both lungs. Renal biopsy showed thrombotic microangiopathic nephropathy. Based upon his medical records, physical examination findings and laboratory data, he was diagnosed as having idiopatic HES with renal involvement. We found FIP1-like-1-platelet-derived growth factor receptor-α(FIP1L1-PDGFRα) gene rearrangement on BM aspiration. He was treated with oral glucocorticoid and tyrosine kinase inhibitor (imatinib mesylate). His symptoms were improved and proteinuria disappeared.
참고문헌 (15)
- Roufosse F, "Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations", Haematologica, 94, pp.1188~93 (2009)
- Motellon JL, "Renal involvement in the hypereosinophilic syndrome", Nephrol Dial Transplant, 10, pp.401~3 (1995)
- Bulucu F, "Renal involvement in a patient with idiopathic hypereosinophilic syndrome", Clin Nephrol, 57, pp.171~3 (2002)
- Andersen CL, "Eosinophilia - pathogenesis, classification and therapy", Ugeskr Laeger, 171, pp.3256~62 (2009)
- Bain BJ, "Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome", Immunol Allergy Clin North Am, 27, pp.377~88 (2007)
- Bain BJ, "Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome", Br J Haematol, 95, pp.2~9 (1996)
- Fletcher S, "Diagnosis and treatment of hypereosinophilic syndromes", Curr Opin Hematol, 14, pp.37~42 (2007)
- Helbig G, "T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome", Haematologica, 94, pp.1263~41 (2009)
- Lierman E, "Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia", Expert Rev Anticancer Ther, 9, pp.1295~304 (2009)
- Razaq W, "Successful treatment of refractory idiopathic hypereosinophilic syndrome with etoposide" (2009), Epub ahead of print
- Sethi S, "A unique case of hypereosinophilic syndrome presenting with dysphagia", South Med J, 102, pp.1091~2 (2009)
- Omernik A, "Solid focal lesions in the lungs as first sign of hypereosinophilic syndrome", Pol Merkur Lekarski, 27, pp.229~31 (2009)
- Choi YJ, "Immunotactoid glomerulopathy associated with idiopathic hypereosinophilic syndrome", Am J Nephrol, 18, pp.337~43 (1998)
- Anghel G, "Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement", Tumori, 91, pp.67~70 (2005)
- Weller PF, "The idiopathic hypereosinophilic syndrome", Blood, 83, pp.2759~79 (1994)
